Publication | Closed Access
A phase I intermittent dose-escalation trial of ZD1839 (Iressa) in Japanese patients with solid malignant tumors
40
Citations
0
References
2000
Year
Japanese PatientsMedicineMetronomic TherapyPharmacotherapyDose-escalation TrialCancer TreatmentOncologyRadiation OncologySolid Malignant TumorsRadiologyHealth Sciences
No additional data available for this publication yet. Check back later!